Dysfunctions in Dopamine Systems and ADHD: Evidence From Animals and Modeling
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Animal models are useful for characterizing neural substrates of neuropsychiatric disorders. Several models have been proposed for the study of Attention Deficit Hyperactivity Disorder (ADHD). The models can be divided into various groups: (i) genetically derived hyperactivity/ inattention, (ii) animal models showing symptoms after pharmacological intervention, and (iii) those based on spontaneous variations in a random population. Spontaneously hypertensive (SHR) and Naples High Excitability (NHE) rats show behavioral traits featuring the main aspects of ADHD in humans but show different changes in dopamine (DA) systems. In fact, the enzyme tyrosine hydroxylase is hyperexpressed in NHE rats and hypoexpressed in SHR. The DA transporter is hyperexpressed in both lines, although in the SHR, DAT activity is low (reduced DA uptake). The DA levels in the striatum and prefrontal cortex are increased in the juvenile SHR, but are decreased in handled young and non‐handled older animals. The mRNA of the D1 DA receptor is upregulated in the prefrontal cortex of SHR and downregulated in NHE. The D2 DA receptors are likely to be hypofunctioning in SHR, although the experimental evidence is not univocal, whereas their mRNA is hyperexpressed in NHE. Thus, in SHR both the mesocortical and mesolimbic DA pathways appear to be involved, whereas in NHE only the mesocortical system. To understand the effects of methylphenidate, the elective ADHD drug treatment in humans, in a dysfunctioning DA system, we realized a simple mathematical model of DA regulation based on experimental data from electrophysiological, cyclic voltammetry, and microdialysis studies. This model allows the estimation of a higher firing frequency of DA neurons in SHR rats and suggests that methylphenidate increases attentive processes by regulating the firing rate of DA neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Getting formal with dopamine and reward
Schultz, W. (2002) · Neuron · doi:10.1016/s0896-6273(02)00967-4 · Cited by 2,574
Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder
Castellanos, F. X. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830070053009 · Cited by 1,183 · cited 10×
“Moreover, ADHD morphofunctional substrates are likely to be the same in rats and humans.”
BackgroundInfluentialFloresco, S. B., West, A. R., Ash, B., Moore, H., & Grace, A. A. (2003) · Nature Neuroscience · doi:10.1038/nn1103 · Cited by 1,106
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885
Solanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677 · cited 1×
“Therapeutic doses of methylphenidate, which are very low, should act to decrease DA-eatecholamine transmission (Seeman & Madras, 1998; Solanto, 1998).”
BackgroundVolkow, N. D., Wang, G., Fowler, J. S., Logan, J., Franceschi, D., Maynard, L., Ding, Y., Gatley, S. J., Gifford, A., Zhu, W., et al. (2002) · Synapse · doi:10.1002/syn.10038 · Cited by 321
Altered responsiveness to cocaine in rats exposed to methylphenidate during development
Andersen, S. L., Arvanitogiannis, A., Pliakas, A. M., LeBlanc, C., & Carlezon, W. A. (2002) · Nature Neuroscience · doi:10.1038/nn777 · Cited by 259
Anti-hyperactivity medication: methylphenidate and amphetamine
Seeman, P., & Madras, B. K. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000421 · Cited by 252
Animal models of attention-deficit hyperactivity disorder.
Davids, E., Zhang, K., Tarazi, F. I., & Baldessarini, R. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00274-6 · Cited by 250 · cited 1×
“The models comprise mice, rats, and monkeys (see also Comings, 2001; Davies et al., 2001; Davids et al., 2003).”
Background
Cited by
del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.036 · Cited by 685
Guzman, M. L., Rossi, R. M., Karnischky, L., Li, X., Peterson, D. R., Howard, D. S., & Jordan, C. T. (2005) · Blood · doi:10.1182/blood-2004-10-4135 · Cited by 678
Scheres, A., Milham, M. P., Knutson, B., & Castellanos, F. X. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.042 · Cited by 499
Guzman, M. L., Rossi, R. M., Neelakantan, S., Li, X., Corbett, C. A., Hassane, D. C., Becker, M. W., Bennett, J. M., Sullivan, E., Lachowicz, J. L., et al. (2007) · Blood · doi:10.1182/blood-2007-05-090621 · Cited by 403
Arnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363
Scheres, A., Dijkstra, M., Ainslie, E., Balkan, J., Reynolds, B., Sonuga-Barke, E., & Castellanos, F. X. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2005.10.012 · Cited by 327
Sleep Disturbances in Children with Attention Deficit Hyperactivity Disorder
O'Brien, L. M., Ivanenko, A., Crabtree, V. M., Holbrook, C. R., Bruner, J. L., Klaus, C. J., & Gozal, D. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000072333.11711.9a · Cited by 172
Newman, L. A., Darling, J., & McGaughy, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1097-8 · Cited by 137
“Converging lines of data suggest that NE dysfunction underlies the symptoms of ADD (Friedman 1999; Viggiano et al. 2004a; Arnsten and Li 2005; Arnsten 2006; Faraone and Khan 2006), and our data support the hypothesis that atomoxetine can remediate cognitive deficits associated with noradrenergic…”
Leukemia stem cells in a genetically defined murine model of blast-crisis CML.
Neering, S. J., Bushnell, T., Sozer, S., Ashton, J., Rossi, R. M., Wang, P.-Y., Bell, D. R., Heinrich, D., Bottaro, A., & Jordan, C. T. (2007) · Blood · doi:10.1182/blood-2007-02-073031 · Cited by 129
Carmona, S., Proal, E., Hoekzema, E. A., Gispert, J.-D., Picado, M., Moreno, I., Soliva, J. C., Bielsa, A., Rovira, M., Hilferty, J., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.013 · Cited by 109
Sleep disturbances in children with attention-deficit/hyperactivity disorder
Spruyt, K., & Gozal, D. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.7 · Cited by 107
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters
Bermingham, D. P., & Blakely, R. D. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012260 · Cited by 97
Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder
Badgaiyan, R. D., Sinha, S., Sajjad, M., & Wack, D. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137326 · Cited by 84
“These findings have prompted many investigators to suggest that ADHD is a hyperdopaminergic condition [16], particularly because increased dopaminergic activity is known to induce motor hyperactivity and impairment of inhibitory control [21].”
BackgroundAtomoxetine facilitates attentional set shifting in adolescent rats
Cain, R. E., Wasserman, M. C., Waterhouse, B. D., & McGaughy, J. A. (2011) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2011.04.003 · Cited by 55
Immunologic and neurodevelopmental susceptibilities of autism
Pessah, I. N., Seegal, R. F., Lein, P. J., LaSalle, J., Yee, B. K., Van De Water, J., & Berman, R. F. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2008.02.006 · Cited by 51
“, 2003), increased tissue concentrations of DA receptors, decreased NE function in PFC and striatum (Viggiano et al., 2004) and increased DAT densities (Watanabe et al.”
Background
Metadata
- Authors
- Viggiano, D., Vallone, D., & Sadile, A.
- Venue
- Neural Plasticity
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 11
- Issue
- 1-2
- Pages
- 97-114
- ISSN
- 1687-5443 (ISSN-L)
- 2090-5904
- OpenAlex
- W1980493703
- Cited by
- 146
- References
- 13
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.